Erik C. Emerson

Insider Reports History

Location
Las Vegas, NV
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erik C. Emerson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apimeds Pharmaceuticals US, Inc. Chief Executive Officer, Director Common Stock, par value $0.01 per share 750K $1.31M $1.75 16 May 2025 Direct
Odyssey Health, Inc. Chief Commerical Officer Stock Option (Right to Buy) 37.5K $3.19K $0.09 16 Jan 2024 Direct
Apimeds Pharmaceuticals US, Inc. Chief Executive Officer, Director Stock Option (right to buy) 215K 15 Oct 2025 Direct

Insider Reports Filed by Erik C. Emerson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APUS Apimeds Pharmaceuticals US, Inc. 15 Oct 2025 1 $0 4 Chief Executive Officer, Director 17 Oct 2025, 18:37
APUS Apimeds Pharmaceuticals US, Inc. 16 May 2025 2 $0 4 Chief Executive Officer, Director 20 May 2025, 16:56
APUS Apimeds Pharmaceuticals US, Inc. 04 Mar 2025 0 $0 3 Chief Executive Officer, Director 08 May 2025, 16:54
ODYY Odyssey Health, Inc. 16 Jan 2024 1 $3.19K 4 Chief Commerical Officer 18 Jan 2024, 17:10
ODYY Odyssey Health, Inc. 29 Dec 2023 1 $20K 4 Chief Commerical Officer 02 Jan 2024, 17:10
ODYY Odyssey Health, Inc. 01 Nov 2022 2 $150K 4 Chief Commercial Officer 23 Nov 2022, 15:02
ODYY Odyssey Health, Inc. 01 Nov 2022 0 $0 3 Chief Commercial Officer 23 Nov 2022, 15:01